Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN)
- PMID: 21413945
- PMCID: PMC3087908
- DOI: 10.1111/j.1365-2249.2011.04379.x
Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN)
Abstract
The description of highly exposed individuals who remain seronegative (HESN) despite repeated exposure to human immunodeficiency virus (HIV)-1 has heightened interest in identifying potential mechanisms of HIV-1 resistance. HIV-specific humoral and T cell-mediated responses have been identified routinely in HESN subjects, although it remains unknown if these responses are a definitive cause of protection or merely a marker for exposure. Approximately half of HESN lack any detectible HIV-specific adaptive immune responses, suggesting that other mechanisms of protection from HIV-1 infection also probably exist. In support of the innate immune response as a mechanism of resistance, increased natural killer (NK) cell activity has been correlated with protection from infection in several high-risk cohorts of HESN subjects, including intravenous drug users, HIV-1 discordant couples and perinatally exposed infants. Inheritance of protective NK KIR3DL1(high) and KIR3DS1 receptor alleles have also been observed to be over-represented in a high-risk cohort of HESN intravenous drug users and HESN partners of HIV-1-infected subjects. Other intrinsic mechanisms of innate immune protection correlated with resistance in HESN subjects include heightened dendritic cell responses and increased secretion of anti-viral factors such as β-chemokines, small anti-viral factors and defensins. This review will highlight the most current evidence in HESN subjects supporting the role of epithelial microenvironment and the innate immune system in sustaining resistance against HIV-1 infection. We will argue that as a front-line defence the innate immune response determines the threshold of infectivity that HIV-1 must overcome to establish a productive infection.
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.
Figures
Similar articles
-
Innate activation of MDC and NK cells in high-risk HIV-1-exposed seronegative IV-drug users who share needles when compared with low-risk nonsharing IV-drug user controls.J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):264-73. doi: 10.1097/QAI.0000000000000470. J Acquir Immune Defic Syndr. 2015. PMID: 25514793 Free PMC article.
-
Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women.Microbiol Spectr. 2021 Oct 31;9(2):e0047021. doi: 10.1128/Spectrum.00470-21. Epub 2021 Oct 27. Microbiol Spectr. 2021. PMID: 34704803 Free PMC article.
-
Functional Perturbation of Mucosal Group 3 Innate Lymphoid and Natural Killer Cells in Simian-Human Immunodeficiency Virus/Simian Immunodeficiency Virus-Infected Infant Rhesus Macaques.J Virol. 2020 Feb 14;94(5):e01644-19. doi: 10.1128/JVI.01644-19. Print 2020 Feb 14. J Virol. 2020. PMID: 31801861 Free PMC article.
-
Mucosal correlates of protection in HIV-1-exposed sero-negative persons.Am J Reprod Immunol. 2014 Aug;72(2):219-27. doi: 10.1111/aji.12202. Epub 2014 Jan 16. Am J Reprod Immunol. 2014. PMID: 24428610 Free PMC article. Review.
-
Genetic and epigenetic regulation of natural resistance to HIV-1 infection: new approaches to unveil the HESN secret.Expert Rev Clin Immunol. 2020 Apr;16(4):429-445. doi: 10.1080/1744666X.2020.1732820. Epub 2020 Mar 5. Expert Rev Clin Immunol. 2020. PMID: 32085689 Review.
Cited by
-
Natural killer cell phenotype is altered in HIV-exposed seronegative women.PLoS One. 2020 Sep 1;15(9):e0238347. doi: 10.1371/journal.pone.0238347. eCollection 2020. PLoS One. 2020. PMID: 32870938 Free PMC article.
-
Prevention of SHIV transmission by topical IFN-β treatment.Mucosal Immunol. 2016 Nov;9(6):1528-1536. doi: 10.1038/mi.2015.146. Epub 2016 Feb 3. Mucosal Immunol. 2016. PMID: 26838048 Free PMC article.
-
Role of Different Subpopulations of CD8+ T Cells during HIV Exposure and Infection.Front Immunol. 2017 Aug 7;8:936. doi: 10.3389/fimmu.2017.00936. eCollection 2017. Front Immunol. 2017. PMID: 28824656 Free PMC article. Review.
-
NK and CD4+ T cell cooperative immune responses correlate with control of disease in a macaque simian immunodeficiency virus infection model.J Immunol. 2012 Aug 15;189(4):1878-85. doi: 10.4049/jimmunol.1201026. Epub 2012 Jul 13. J Immunol. 2012. PMID: 22798665 Free PMC article.
-
Involvement of neutrophil hyporesponse and the role of Toll-like receptors in human immunodeficiency virus 1 protection.PLoS One. 2015 Mar 18;10(3):e0119844. doi: 10.1371/journal.pone.0119844. eCollection 2015. PLoS One. 2015. PMID: 25785697 Free PMC article.
References
-
- Fowke KR, Nagelkerke NJ, Kimani J, et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet. 1996;348:1347–51. - PubMed
-
- Jennes W, Verheyden S, Demanet C, et al. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J Immunol. 2006;177:6588–92. - PubMed
-
- Beretta A, Furci L, Burastero S, et al. HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection. Immunol Lett. 1996;51:39–43. - PubMed
-
- Clerici M, Giorgi JV, Chou CC, et al. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis. 1992;165:1012–9. - PubMed
-
- Mazzoli S, Trabattoni D, Lo Caputo S, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med. 1997;3:1250–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources